News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
498,997 Results
Type
Article (36714)
Company Profile (157)
Press Release (462126)
Section
Business (149903)
Career Advice (1541)
Deals (28865)
Drug Delivery (101)
Drug Development (69554)
Employer Resources (125)
FDA (11749)
Job Trends (11318)
News (267387)
Policy (29382)
Tag
Academia (1944)
Alliances (46411)
Alzheimer's disease (1089)
Approvals (11711)
Artificial intelligence (119)
Bankruptcy (266)
Best Places to Work (8804)
Breast cancer (144)
Cancer (1099)
Cardiovascular disease (84)
Career advice (1294)
Cell therapy (219)
Clinical research (55670)
Collaboration (443)
Compensation (225)
COVID-19 (2496)
C-suite (86)
Data (1085)
Diabetes (153)
Diagnostics (3932)
Drug pricing (93)
Earnings (54031)
Employer resources (113)
Events (66358)
Executive appointments (288)
FDA (12296)
Funding (308)
Gene therapy (168)
GLP-1 (637)
Government (4226)
Healthcare (12471)
Infectious disease (2589)
Inflammatory bowel disease (90)
Interviews (265)
IPO (12274)
Job creations (2898)
Job search strategy (1124)
Layoffs (325)
Legal (7784)
Lung cancer (159)
Lymphoma (84)
Manufacturing (195)
Medical device (6461)
Medtech (6464)
Mergers & acquisitions (16745)
Metabolic disorders (445)
Neuroscience (1355)
NextGen Class of 2024 (4265)
Non-profit (2973)
Northern California (1233)
Obesity (264)
Opinion (201)
Patents (108)
People (40378)
Phase I (16561)
Phase II (24279)
Phase III (19329)
Pipeline (430)
Policy (83)
Postmarket research (2231)
Preclinical (6947)
Radiopharmaceuticals (225)
Rare diseases (208)
Real estate (4073)
Regulatory (18728)
Research institute (1801)
Resumes & cover letters (226)
Southern California (1038)
Startups (2643)
United States (10567)
Vaccines (609)
Weight loss (213)
Date
Today (72)
Last 7 days (443)
Last 30 days (1773)
Last 365 days (26446)
2024 (26333)
2023 (29743)
2022 (39221)
2021 (42077)
2020 (40258)
2019 (33347)
2018 (25549)
2017 (25253)
2016 (24090)
2015 (27823)
2014 (22008)
2013 (18296)
2012 (19516)
2011 (20307)
2010 (18643)
Location
Africa (689)
Arizona (97)
Asia (33245)
Australia (5327)
California (2695)
Canada (1130)
China (251)
Colorado (124)
Connecticut (123)
Europe (73608)
Florida (390)
Georgia (86)
Illinois (262)
Indiana (165)
Maryland (514)
Massachusetts (2051)
Michigan (92)
Minnesota (127)
New Jersey (872)
New York (803)
North Carolina (526)
Northern California (1233)
Ohio (98)
Pennsylvania (630)
South America (994)
Southern California (1038)
Texas (352)
Washington State (257)
498,997 Results for "phenex pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Deals
OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals
OrsoBio, Inc. today announced its acquisition of assets relating to the Liver X Receptor (LXR) inverse agonist program from Phenex Pharmaceuticals, including lead candidate TLC-2716 and associated intellectual property.
November 2, 2022
·
5 min read
Press Releases
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
November 21, 2024
·
7 min read
Biotech Bay
Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older
Mirum Pharmaceuticals, Inc. has adopted a positive opinion of LIVMARLI® (maralixibat) oral solution for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) in patients three months of age and older.
May 31, 2024
·
8 min read
BioCapital
Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal
Telomir Pharmaceuticals, Inc. announced that Michael F. Roizen, MD, a leader in age-related medicine and an existing advisor to the Company, will be increasing his role in the coming months as a Special Advisor on Age Reversal.
March 5, 2024
·
5 min read
Business
Alamar Biosciences and Biomarkers of Aging Consortium Join Forces to Revolutionize Longevity Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium announced the launch of the next phase of the Biomarkers of Aging Challenge Series.
June 27, 2024
·
3 min read
Press Releases
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration
October 25, 2024
·
12 min read
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
Sirona Biochem Corp. is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare’s newly published research report, “Novel Treatments for Age-Related Skin Problems.” The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market.
June 18, 2024
·
3 min read
BioCapital
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
Telomir Pharmaceuticals, Inc.(Nasdaq:TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical company focused on Telomir-1 as a potential treatment for age-related conditions, today recapped its presentation of compelling pre-clinical data on Telomir-1 at a high-profile event hosted at the National Press Club in Washington, D.C., on April 15, 2024.
April 16, 2024
·
6 min read
1 of 49,900
Next
